VILASINI SHETTY, Ph.D., CCRP

** ********, **. • Oak Brook, IL 60523 • 708-***-****

ad0k2v@r.postjobfree.com

A C A D E M I C QUALIFICATIONS

Certified Clinical Research Professional through SOCRA 2003 Ph.D. (Oncology), Bombay/London University 1992

Thesis: Immunophenotyping and ultrastructural study of acute leukemia. MS (Applied Biology), Bombay University, India 1986 Thesis: Study of infantile diarrhea with special reference to rotavirus. BS (Microbiology/Chemistry), Bombay University, India 1982 P O S I T I O N S H E L D

Pfizer, New York, NY - Dec 2012 – Present

Field Medical Director, Oncology Business Unit

Pfizer, New York, NY - Mar 2005 – Nov 2012

Associate Director, Oncology Business Unit

Berlex Laboratories, Seattle, WY Dec 2003 – Feb 2005 Scientific Liaison

Rush University Medical Center, Chicago, IL - Oct 1997 - Nov 2003 Assistant Professor, Rush Cancer Institute - Department of Medicine Rush University Medical Center, Chicago, IL - Oct 1994 - Apr 1997 Instructor, Rush Cancer Institute, Department of Medicine Jaslok Hospital & Research Center, Bombay, India - Mar 1991 - Oct 1992 Senior Research Fellow

Institute of Cancer Research & Royal Marsden Hospital, London, U.K. - Mar 1989 - Feb 1991 Senior Research Fellow

P R O F E S S I O N A L E X P E R I E N C E

Field Medical (FM) Lead for Lung Cancer, Colorectal Cancer on the GI-Skin-Lung (GSL) team. Core team member on the recent Prostate Cancer Launch team.

FM lead on the Publication Steering Committee to support the launch activities. Responsible for working with team on developing of scientific publications strategic plan and reporting of company sponsored studies.

FM Lead for heme assets (Bosutinib, Inotuzumab Ozogamicin, Glasdegib Primarily responsible for providing approved medical content on heme assets to regional HCPs and cross-functional committee. Represented the team on Launch, IIR strategy, Payer presentation, Training, and Publication Committee. Led the timely approval of medical content by the Medical Review Committee (MRC) for TAFMD use in the field.

FM Lead for Pathways across all therapeutic areas. Responsible for the strategy and smooth functioning of the pathway workstream. Timely submission of clinical evidence to ClinicalPath, McKesson, AIM, NCH & United Healthcare pathways.

Led the FM activities for Sunitinib launch, Bosutinib launch and Co-led the Inotuzumab Ozogamicin launch.

Contributed to the COVID-19 program in Oncology

Contributed to the medical planning, publication strategy, and work with Payer & cross-therapeutic leadership to develop and implement the FM team medical plans for Bosutinib in CML, Inotuzumab in ALL, Lorlatinib in Alk+ NSCLC, Crizotinib in IMT, Encorafenib in CRC and Sunitinib in RCC.

Represented FM on Congress Planning teams (ASH, ASCO). Lead FM planning for major oncology congress/symposium

Excellent oral and communications skills with a proven track record of publications and presentations as invited speaker at national and international meetings and assisting in writing program projects and grants at a federal level

As a laboratory supervisor at Rush Cancer Center, was responsible for the direct supervision of 25 laboratory personnel that included full time laboratory technician, summer students, research trainees, medical residents rotating through the laboratory and a post-doctoral fellow.

P F I Z E R R E C O G N I T I O N AWARDS

2023 - Pfizer Oncology “Altitude” award for the critical role played in cross collaboration activities in the North Central MI accounts

2015 - Pfizer Oncology “Take the Leap” award for the critical role played in Ibrance payer support both pre-approval and peri-launch as Humana and Caremark added Ibrance to their coverage plans within 10 days of Ibrance FDA-approval, much earlier than historically occurs with a new oncology product

2011 – RMRS Recognition Award

P R O F E S S I O N A L A C C OMPLISHMENTS

Published 45 articles and 141 abstracts on heme malignancies in internationally reputed journals.

Authored a book chapter on MDS.

Invited speaker at fifteen different national and international conferences.

Oral and poster presentation at seven different national conferences.

Biographic citation in the Millennium 5th Edition of Who’s who in Science and Engineering in America.

Cited in the Millennium Edition of Who’s Who of American Women and the 55th edition of Who’s Who in America MEMBERSHIPS

Active member of American Society of Clinical Oncology (ASCO).

Member of the Society of Clinical Research Associates.

Member of Women in Cancer Research, USA.

C OMPUTER S K I L L S

Well versed in using MS Word, Excel, PowerPoint, Word Perfect and familiar with KaleidaGraph and SPSS.

Contact this candidate